Susquehanna International Group’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Hold
0
-$64K 10159
2018
Q1
Hold
0
8874
2017
Q4
Hold
0
8818
2017
Q3
Sell
-1
Closed -$209K 8644
2017
Q2
$314K Hold
1
﹤0.01% 7516
2017
Q1
$310K Buy
+1
New +$381K ﹤0.01% 7286
2016
Q2
Hold
0
-$26K 9125
2016
Q1
Hold
0
8785
2015
Q4
Hold
0
9003
2015
Q3
Hold
0
7845
2015
Q2
Hold
0
6991
2015
Q1
Hold
0
7420
2014
Q4
Hold
0
9343
2014
Q3
Hold
0
7109
2014
Q2
Hold
0
6926

Other funds holding PALI

Susquehanna International Group's PALI Position: Q1 2026 in Review

Susquehanna International Group sold out of Palisade Bio (PALI) in Q1 2026, closing a stake of 212,659 shares — an estimated $500K sold.

Susquehanna International Group first reported a position in PALI in Q2 2015 and held it in 4 quarters. The position peaked at $1.72M in Q2 2015. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Susquehanna International Group reported no remaining Palisade Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 212,659 Palisade Bio shares in Q1 2026, an estimated $500K.
  • Susquehanna International Group first reported a position in Palisade Bio in Q2 2015 and held it in 4 quarters.
  • Susquehanna International Group's Palisade Bio position peaked at $1.72M in Q2 2015.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.